150 related articles for article (PubMed ID: 11035573)
1. Relationship of myoma cell size and menopausal status in small uterine leiomyomas.
Cramer SF; Marchetti C; Freedman J; Padela A
Arch Pathol Lab Med; 2000 Oct; 124(10):1448-53. PubMed ID: 11035573
[TBL] [Abstract][Full Text] [Related]
2. The relation of fibrous degeneration to menopausal status in small uterine leiomyomas with evidence for postmenopausal origin of seedling myomas.
Cramer SF; Horiszny J; Patel A; Sigrist S
Mod Pathol; 1996 Jul; 9(7):774-80. PubMed ID: 8832561
[TBL] [Abstract][Full Text] [Related]
3. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
4. Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
Polatti F; Viazzo F; Colleoni R; Nappi RE
Maturitas; 2000 Nov; 37(1):27-32. PubMed ID: 11099870
[TBL] [Abstract][Full Text] [Related]
5. Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors.
Seidel V; Wernecke KD; Bellingkrodt AL; Armbrust R; David M
Geburtshilfe Frauenheilkd; 2023 Apr; 83(4):446-452. PubMed ID: 37034415
[No Abstract] [Full Text] [Related]
6. Significance of postmenopausal uterine leiomyomas: Focus on variants.
Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
[TBL] [Abstract][Full Text] [Related]
7. The level of typical biomarker of oxidative stress 8-hydroxy-2'-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor.
Foksinski M; Kotzbach R; Szymanski W; Olinski R
Free Radic Biol Med; 2000 Oct; 29(7):597-601. PubMed ID: 11033411
[TBL] [Abstract][Full Text] [Related]
8. Myoma Imaging by Gynecologic Surgeons Training in Intraoperative Ultrasound Technique.
Bent RE; Wilson MD; Jacoby VL; Varon S; Parvataneni R; Saberi N; Waetjen LE
J Minim Invasive Gynecol; 2019; 26(6):1139-1143. PubMed ID: 30502500
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic abnormalities in uterine myomas are associated with myoma size.
Rein MS; Powell WL; Walters FC; Weremowicz S; Cantor RM; Barbieri RL; Morton CC
Mol Hum Reprod; 1998 Jan; 4(1):83-6. PubMed ID: 9510016
[TBL] [Abstract][Full Text] [Related]
10. The growth of uterine myomas in untreated women: influence factors and ultrasound monitoring.
Armbrust R; Wernecke KD; Sehouli J; David M
Arch Gynecol Obstet; 2018 Jan; 297(1):131-137. PubMed ID: 29063234
[TBL] [Abstract][Full Text] [Related]
11. [Uterine leiomyoma: pathology and epidemiology].
Cabrera J; Mucientes F; Klaassen R; Acosta S; Oliva JP
Rev Chil Obstet Ginecol; 1994; 59(1):39-43. PubMed ID: 7809431
[TBL] [Abstract][Full Text] [Related]
12. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB).
Lasmar RB; Lasmar BP
Best Pract Res Clin Obstet Gynaecol; 2017 Apr; 40():82-88. PubMed ID: 27784616
[TBL] [Abstract][Full Text] [Related]
13. Acute abdomen caused by internodular bleeding from a multiple myoma pseudocapsule in a postmenopausal woman.
Yokoe T; Fukuda H; Noda Y; Kita M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37793842
[TBL] [Abstract][Full Text] [Related]
14. Symptoms of uterine myomas: data of an epidemiological study in Germany.
Foth D; Röhl FW; Friedrich C; Tylkoski H; Rabe T; Römer T; Kitay A; Ahrendt HJ
Arch Gynecol Obstet; 2017 Feb; 295(2):415-426. PubMed ID: 27873052
[TBL] [Abstract][Full Text] [Related]
15. Processes of apoptosis and cell proliferation in uterine myomas originating from reproductive and perimenopausal women.
Plewka A; Plewka D; Madej P; Nowaczyk G; Sieron-Stoltny K; Jakubiec-Bartnik B
Folia Histochem Cytobiol; 2011; 49(3):398-404. PubMed ID: 22038217
[TBL] [Abstract][Full Text] [Related]
16. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
Carranza Lira S
Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
[TBL] [Abstract][Full Text] [Related]
17. Transvaginal Doppler examination of uteri with myomas.
Sladkevicius P; Valentin L; Marsál K
J Clin Ultrasound; 1996; 24(3):135-40. PubMed ID: 8838302
[TBL] [Abstract][Full Text] [Related]
18. Vascularity of uterine myomas: assessment by color and pulsed Doppler ultrasound.
Sosić A; Skupski DW; Streltzoff J; Yun H; Chervenak FA
Int J Gynaecol Obstet; 1996 Sep; 54(3):245-50. PubMed ID: 8889632
[TBL] [Abstract][Full Text] [Related]
19. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S; Asano R; Wakabayashi R; Hayashi H; Shigeta H
BMC Womens Health; 2022 Aug; 22(1):346. PubMed ID: 35974345
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
Higashijima T; Kataoka A; Nishida T; Yakushiji M
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
